Figure 1 shows the frequency of the most common genetic alterations found in CRC tumors for PRH leading to deregulation of the WNT/β‐catenin, MAPK, PI3K, TGF‐β, and p53 signaling pathways. This evidence concerns the gene TP53 and colorectal carcinoma.